22 May 2025
The new global era of patient care with CathWorks FFRangio
Sponsored by CathWorks and Medtronic
Anchorperson:
R. Al-Lamee
Spokesperson:
R. Kornowski
Summary
This EuroPCR 2025 session highlights how CathWorks FFRangio is reshaping coronary physiology assessment worldwide. Through case-based experience and real-world data, it showcases the integration of FFRangio into routine clinical workflows—from early adoption at Clinique Pasteur in Toulouse to implementation across the UK. The session also presents the growing body of diagnostic and clinical outcome evidence, along with a look at how FFRangio is evolving toward becoming a new standard of care in the cathlab.
Learning Objectives
- To explore the practical application of FFRangio in routine practice
- To learn from centers with short- and long-term experience
- To be updated on diagnostic and clinical outcome evidence